{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:11:48Z","timestamp":1789931508135,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501503"],"award-info":[{"award-number":["81501503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes Program","award":["14DZ2251400"],"award-info":[{"award-number":["14DZ2251400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11307-018-1277-9","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T15:50:24Z","timestamp":1536940224000},"page":"538-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictive Value of [18F]ML-10 PET\/CT in Early Response Evaluation of Combination Radiotherapy with Cetuximab on Nasopharyngeal Carcinoma"],"prefix":"10.1007","volume":"21","author":[{"given":"Bingxin","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"1277_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1277_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"MLK Chua","year":"2016","unstructured":"Chua MLK, Wee JTS, Hui EP, Chan ATC (2016) Nasopharyngeal carcinoma. Lancet 387:1012\u20131024","journal-title":"Lancet"},{"key":"1277_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP, MAC-NPC Collaborative Group (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 16:645\u2013655","journal-title":"Lancet Oncol"},{"key":"1277_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ceb.2007.02.008","volume":"19","author":"EM Bublil","year":"2007","unstructured":"Bublil EM, Yarden Y (2007) The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol 19:124\u2013134","journal-title":"Curr Opin Cell Biol"},{"key":"1277_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/ol.2014.2631","volume":"9","author":"P Zhang","year":"2015","unstructured":"Zhang P, Wu SK, Wang Y et al (2015) p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: a retrospective study. Oncol Lett 9:113\u2013118","journal-title":"Oncol Lett"},{"key":"1277_CR6","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1200\/JCO.2005.02.147","volume":"23","author":"AT Chan","year":"2005","unstructured":"Chan AT, Hsu MM, Goh BC et al (2005) Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 23:3568\u20133576","journal-title":"J Clin Oncol"},{"key":"1277_CR7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/annonc\/mdr401","volume":"23","author":"BB Ma","year":"2012","unstructured":"Ma BB, Kam MK, Leung SF et al (2012) A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 23:1287\u20131292","journal-title":"Ann Oncol"},{"key":"1277_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.ijrobp.2011.02.062","volume":"82","author":"M Suntharalingam","year":"2012","unstructured":"Suntharalingam M, Kwok Y, Goloubeva O, Parekh A, Taylor R, Wolf J, Zimrin A, Strome S, Ord R, Cullen KJ (2012) Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 82:1845\u20131850","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1277_CR9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.2967\/jnumed.107.043919","volume":"49","author":"A Reshef","year":"2008","unstructured":"Reshef A, Shirvan A, Waterhouse RN, Grimberg H, Levin G, Cohen A, Ulysse LG, Friedman G, Antoni G, Ziv I (2008) Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med 49:1520\u20131528","journal-title":"J Nucl Med"},{"key":"1277_CR10","doi-asserted-by":"publisher","unstructured":"(2013) Poster Presentation. J Label Compd Radiopharm 56:S88\u2013S462. \n                    https:\/\/doi.org\/10.1002\/jlcr.3058","DOI":"10.1002\/jlcr.3058"},{"key":"1277_CR11","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/jnci\/djr432","volume":"103","author":"QY Chen","year":"2011","unstructured":"Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ (2011) Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst 103:1761\u20131770","journal-title":"J Natl Cancer Inst"},{"key":"1277_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","volume":"110","author":"AW Lee","year":"2014","unstructured":"Lee AW, Ng WT, Chan LL et al (2014) Evolution of treatment for nasopharyngeal cancer\u2014success and setback in the intensity-modulated radiotherapy era. Radiother Oncol 110:377\u2013384","journal-title":"Radiother Oncol"},{"key":"1277_CR13","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","volume":"24","author":"X Wu","year":"2013","unstructured":"Wu X, Huang PY, Peng PJ, Lu LX, Han F, Wu SX, Hou X, Zhao HY, Huang Y, Fang WF, Zhao YY, Xue C, Hu ZH, Zhang J, Zhang JW, Ma YX, Liang WH, Zhao C, Zhang L (2013) Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 24:2131\u20132136","journal-title":"Ann Oncol"},{"key":"1277_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ijc.10894","volume":"103","author":"AW Lee","year":"2003","unstructured":"Lee AW, Foo W, Mang O et al (2003) Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality. Int J Cancer 103:680\u2013685","journal-title":"Int J Cancer"},{"key":"1277_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","volume":"374","author":"LL Tang","year":"2016","unstructured":"Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX, Jia WH (2016) Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett 374:22\u201330","journal-title":"Cancer Lett"},{"key":"1277_CR16","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.7314\/APJCP.2015.16.15.6729","volume":"16","author":"Z-X Xu","year":"2015","unstructured":"Xu Z-X, Lin Z-X, Fang J-Y, Wu KS, du PL, Zeng Y, Tang WR, Xu XL, Lin K (2015) Mortality characteristic and prediction of nasopharyngeal carcinoma in China from 1991 to 2013. Asian Pac J Cancer Prev 16:6729\u20136734","journal-title":"Asian Pac J Cancer Prev"},{"key":"1277_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2003.10.038","volume":"59","author":"DTT Chua","year":"2004","unstructured":"Chua DTT, Nicholls JM, Sham JST, Au GKH (2004) Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 59:11\u201320","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1277_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/CBM-140401","volume":"14","author":"X Ma","year":"2014","unstructured":"Ma X, Huang J, Wu X, Li X, Zhang J, Xue L, Li P, Liu L (2014) Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: a meta-analysis. Cancer Biomark 14:267\u2013277","journal-title":"Cancer Biomark"},{"key":"1277_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/annonc\/mdu156","volume":"26","author":"S Trivedi","year":"2015","unstructured":"Trivedi S, Concha-Benavente F, Srivastava RM, Jie HB, Gibson SP, Schmitt NC, Ferris RL (2015) Immune biomarkers of anti-EGFR monoclonal antibody therapy. Ann Oncol 26:40\u201347","journal-title":"Ann Oncol"},{"key":"1277_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1677\/erc.0.0080011","volume":"8","author":"N Prenzel","year":"2001","unstructured":"Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A (2001) The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8:11\u201331","journal-title":"Endocr Relat Cancer"},{"key":"1277_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S1470-2045(08)70073-1","volume":"9","author":"J Bussink","year":"2008","unstructured":"Bussink J, van der Kogel AJ, Kaanders JHAM (2008) Activation of the PI3-K\/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 9:288\u2013296","journal-title":"Lancet Oncol"},{"key":"1277_CR22","doi-asserted-by":"publisher","first-page":"7016907","DOI":"10.1155\/2016\/7016907","volume":"2016","author":"J Gu","year":"2016","unstructured":"Gu J, Yin L, Wu J, Zhang N, Huang T, Ding K, Cao H, Xu L, He X (2016) Cetuximab and cisplatin show different combination effect in nasopharyngeal carcinoma cells lines via inactivation of EGFR\/AKT signaling pathway. Biochem Res Int 2016:7016907","journal-title":"Biochem Res Int"},{"key":"1277_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.radonc.2013.02.001","volume":"106","author":"H Stegeman","year":"2013","unstructured":"Stegeman H, Kaanders JH, van der Kogel AJ, Iida M, Wheeler DL, Span PN, Bussink J (2013) Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models. Radiother Oncol 106:383\u2013389","journal-title":"Radiother Oncol"},{"key":"1277_CR24","first-page":"237","volume":"19","author":"FL Sung","year":"2005","unstructured":"Sung FL, Poon TCW, Hui EP et al (2005) Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells. In Vivo 19:237\u2013245","journal-title":"In Vivo"},{"key":"1277_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1148\/radiology.219.2.r01ma19316","volume":"219","author":"W Ralph","year":"2001","unstructured":"Ralph W, Umar M (2001) Molecular imaging. Radiology 219:316\u2013333","journal-title":"Radiology"},{"key":"1277_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2967\/jnumed.114.144055","volume":"56","author":"M Hatt","year":"2014","unstructured":"Hatt M, Majdoub M, Vallieres M et al (2014) 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med 56:38\u201344","journal-title":"J Nucl Med"},{"key":"1277_CR27","first-page":"549","volume":"44","author":"N Oyama","year":"2003","unstructured":"Oyama N, Miller TR, Dehdashti F et al (2003) 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 44:549\u2013555","journal-title":"J Nucl Med"},{"key":"1277_CR28","first-page":"945","volume":"46","author":"W Chen","year":"2005","unstructured":"Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH (2005) Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med 46:945\u2013952","journal-title":"J Nucl Med"},{"key":"1277_CR29","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1200\/JCO.2005.04.3810","volume":"24","author":"HM Linden","year":"2006","unstructured":"Linden HM, Stekhova SA, Link JM, Gralow JR, Livingston RB, Ellis GK, Petra PH, Peterson LM, Schubert EK, Dunnwald LK, Krohn KA, Mankoff DA (2006) Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol 24:2793\u20132799","journal-title":"J Clin Oncol"},{"key":"1277_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/cr.2009.17","volume":"19","author":"A Cohen","year":"2009","unstructured":"Cohen A, Shirvan A, Levin G (2009) From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res 19:625\u2013637","journal-title":"Cell Res"},{"key":"1277_CR31","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2967\/jnumed.110.081786","volume":"52","author":"J Hoglund","year":"2011","unstructured":"Hoglund J, Shirvan A, Antoni G, Gustavsson SA, Langstrom B, Ringheim A, Sorensen J, Ben-Ami M, Ziv I (2011) 18F-ML-10, a PET tracer for apoptosis: first human study. J Nucl Med 52:720\u2013725","journal-title":"J Nucl Med"},{"key":"1277_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1593\/tlo.13868","volume":"7","author":"MJ Oborski","year":"2014","unstructured":"Oborski MJ, Laymon CM, Qian Y, Lieberman FS, Nelson AD, Mountz JM (2014) Challenges and approaches to quantitative therapy response assessment in glioblastoma multiforme using the novel apoptosis positron emission tomography tracer F-18 ML-10. Transl Oncol 7:111\u2013119","journal-title":"Transl Oncol"},{"key":"1277_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ymeth.2009.03.022","volume":"48","author":"M Saint-Hubert De","year":"2009","unstructured":"De Saint-Hubert M, Prinsen K, Mortelmans L et al (2009) Molecular imaging of cell death. Methods 48:178\u2013187","journal-title":"Methods"},{"key":"1277_CR34","first-page":"242","volume":"1766","author":"AA Neves","year":"2006","unstructured":"Neves AA, Brindle KM (2006) Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta 1766:242\u2013261","journal-title":"Biochim Biophys Acta"},{"key":"1277_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/brb3.217","volume":"4","author":"MJ Oborski","year":"2014","unstructured":"Oborski MJ, Laymon CM, Lieberman FS, Drappatz J, Hamilton RL, Mountz JM (2014) First use of 18F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy. Brain Behav 4:312\u2013315","journal-title":"Brain Behav"},{"key":"1277_CR36","first-page":"1059","volume":"47","author":"LK Shankar","year":"2006","unstructured":"Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA, van den Abbeele A, Yap J, Sullivan D, National Cancer Institute (2006) Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J Nucl Med 47:1059\u20131066","journal-title":"J Nucl Med"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-018-1277-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-018-1277-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-018-1277-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T12:38:20Z","timestamp":1568983100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-018-1277-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1007\/s11307-018-1277-9","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"14 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments met guidelines evaluated and approved by the ethics committee of Fudan University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable institutional and\/or national guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}